Introduction
Colorectal cancer (CRC) is the second most commonly diagnosed type of cancer in females and the third in males worldwide, with an estimated >1.2 million new cancer cases and 608,700 deaths in 2008 (1) . While colon cancer (CC) and rectal cancer (RC) are often referred to as CRC due to their adjacent anatomic location, several studies investigating risk factors to underlying molecular mechanisms, have reported differences between CC and RC.
Dietary risk factors appeared to be considerably different between CC and RC (2) and the Cancer Genome Atlas Network reported differences between tumors located in the right colon and all other sites (3) . Whether CC and RC are of a markedly different nature has not been clearly determined and the number of clinical studies that have emphasized the differences between CC and RC is currently limited.
Several tumor markers, including carcinoembryonic antigen (CEA), carbohydrate antigen (CA) 19.9 and CA 12.5, have been detected in a number of malignancies, including CRC. The levels of CEA and CA19.9 are often elevated in advanced CRC (4) and have been considered as an early sign of CRC recurrence (5) .
CEA, originally identified in human fetal intestine and adult CC tissue in 1965 by Gold and Freedman (6) , was subsequently characterized as a glycosylated cell-surface glycoprotein with a molecular weight of 180,000 Da (7); further research identified it as a significant tumor-associated antigen that is highly overexpressed in breast, lung and pancreatic cancer and, particularly, in CRC (8, 9) . CEA is routinely detected as a tumor biomarker and an auxiliary indicator for the preoperative diagnosis of CRC (10) , as well as an early predictor of recurrence (5), which to some extent accounts for CEA reflecting the nature of CRC.
As there are currently few available studies reporting the variations in the expression of CEA between CC and RC, the present study aimed to investigate the possible differences in The serum CEA concentrations were measured preoperatively in the 240 patients by radioimmunoassays performed in the clinical laboratories of the two affiliated hospitals. CEA kits from Roche Diagnostics (Basel, Switzerland) were used for detection following the manufacturer's instructions. High CEA concentrations were redefined as those >5 ng/ml.
Statistical analysis.
In the present study, all the data were included in the analysis and are expressed as means ± SD. Statistical significance was calculated using the non-parametric t-test and differences were considered to be statistically significant when P<0.05. Table I .
Results

Clinicopathological
Lower CEA level in stage C of CRC differs from that in other stages. The mean value of CEA in patients with CRC in stage A, B, C and D were 34.14, 33.66, 23.35 and 60.05 ng/ml, respectively. Of note, the CEA level in patients with CRC at stage C was lower compared to that in any of the other stages, with significant differences from stages A and D (Fig. 1) , indicating the significance of stage C, which contrasts the previous hypotheses that CEA levels increased with advancing stage (12,13). Additionally, the CEA level of the non-distant metastasis (NDM) group was different from that in the distant metastasis (DM) group, whereas no differences were observed between the non-metastasis (NM) and metastasis (M) groups. An analysis of other factors, such as patient gender and age, revealed no statistically significant differences (Table II) .
CC and RC are generally considered to be of the same nature due to their neighbouring anatomical position. Therefore, the indices of CC and RC are analyzed considering these two types of cancer as a singe entity. In order to investigate the hypothesis that CC and RC may be of different natures, possibly reflected by the differences in the serum CEA level among different stages of CRC ( Fig. 1) , we divided the cases into two groups and analyzed them accordingly. (Table III) , whereas those in RC patients were 47.04, 56.28, 42.29 and 15.34 ng/ml, respectively (Table IV) . The statistical analysis revealed that CC exhibited a more significant variation among the four stages (Fig. 2 ) compared to that in the RC group (Fig. 3) . No differences were observed between male and female patients and between patients aged <50 and >50 years regarding the distribution of serum CEA levels. Fig. 2A . A significant difference was also observed between stages B and D (P=0.0004; Fig. 2B ), whereas no significant difference was observed between stages B and C (P=0.3216). Additionally, due to the high CEA level in stage D coexisting with the lower CEA level in stages A, B and C, a significant difference was also observed between the NDM and DM groups (P<0.0001; Fig. 2D ). However, no difference was observed between the NM and M groups (P=0.5781; Fig. 2C ). There were no differences among other factors, such as patient gender and age (Table III) . (Table V) . However, the CEA level in stage C of CC was lower compared to that in stage C of RC, with a significant difference (P= 0.0096); the difference between stage D of CC and RC was also significant (P= 0.0063) (Fig. 4 ). There were also differences in the CEA level in the NDM group between CC and RC (P=0.0155), whereas there were no differences in the other factors shown in Table V . 
Significant differences in the serum
A B C D Discussion
Previous studies by Midiri et al (13) and Chen et al (12) reported a different tendency of the serum CEA levels in CRC patients with advancing stage. Our results of the present study revealed that the lowest CEA level was observed in stage C, with significant differences from stages A and D. The impacts of patient number, age and gender was not taken into consideration as they could not be controlled in this analysis and there were no differences between them. The physical condition of the patients, including the coexistence of other benign diseases (14), may affect the CEA level to a certain extent. Additionally, the CC/RC ratio, which was reported to be 56/44% by Chen et al (12) and 58.4/41.6% by Lin et al (15) , was different from the 49/51% that was observed in the present study, which may lead to a different tendency if there is internal variation between CC and RC. As regards CC, there was significant variation among stages, with the lowest CEA level in stage C, whereas there was no such variation in RC. In addition, CC and RC are distinguished by the CEA level in stages B (P=0.0327), C (P=0.0092) and D (P=0.0073). We cannot exclude the possibility of a deviation arising due to insufficient patient number (<30 in several stages), patient physical condition and statistical error. To reduce the error arising from the insufficient number of patients, several patients were added to the follow-up study; however, the inner differences between CC and RC were not affected.
Several studies focused on the hypothesis that CC and RC are likely two naturally different diseases; however, the majority of the currently available studies consider CC and RC as a single entity. Wakai et al (2) reported that the dietary risk factors appeared to differ between CC and RC. Li et al (16) reported that the survival of CC patients was significantly superior to that of RC patients. Nielsen et al (17) also reported that a combination of plasma tissue inhibitor of metalloproteinase 1 and CEA may be useful for the early detection of CRC, particularly CC. Additionally, the Cancer Genome Atlas Network has reported certain differences between tumors from the right colon and all other sites (3). This prompted us to investigate whether the differences in the CEA levels between CC and RC, despite the overall close association between CRC and CEA, reflect the fact that CC and RC are of a different nature, which requires further investigation.
The lowest CEA level was observed in stage C of CC, with significant differences from stages A and D. Despite the fact that we added more patients in our subsequent study, we cannot exclude the possibility that the patient number was insufficient for analysis, resulting in the unusually low-level of CEA in stage C, which is inconsistent with the findings of Lee et al (18) , who investigated 233 stage C patients and reported that stage C patients are more significantly associated with increased preoperative CEA levels, as well as the findings of other studies. We also cannot exclude the possibility that there may be a distinction 
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between stage C and other stages in several studies stressing the individual effects of treatment on stage C. Li et al (16) reported that the survival of stage C patients was significantly superior to that of other CRC patients. Stage C refers to those patients suffering from cancer cell metastasis to the lymph nodes. The 5-year overall survival improved as the number of nodes sampled increased for patients with CC (19) and the lymph node ratio is known to be an independent prognostic factor in CC patients with stage C disease (20) . Therefore, the improved survival rate mentioned above for CC patients with stage C disease may be correlated with the number of lymph nodes and should be investigated in the follow-up study. Due to the limited number of studies on stage C of CC, the unique character of stage C possibly plays a significant role in the evolution of CC; however, the underlying mechanisms require further investigation in the follow-up study.
In the present study, we demonstrated that there is variation in CEA levels among different stages in patients with CC, while no such variation was observed among RC patients. Of note, the CEA level in stage C was the lowest among all stages in CC patients. Apart from the factors affecting the results, including age, gender, patient number and physical condition, any unknown internal distinctions between CC and RC and between stage C and other CC stages remain to be further investigated. Elucidating whether there actually is a difference in the nature of CC and RC may have important implications regarding treatment and prognosis of these two types of cancer.
